With the growing acceptance of gender dysphoria, more patients are seeking gender reassignment surgery nowadays. To update clinicians’ knowledge, a research team from Ghent University Hospital in Belgium discussed many of these surgical approaches in a recent literature review.
Archives for 2016
Low-intensity shockwave therapy (LISWT) can be a safe, effective treatment for men with erectile dysfunction (ED) who don’t respond to oral ED medications, according to a recent Sexual Medicine report.
Men with erectile dysfunction (ED) are over three times more likely to develop osteoporosis than men with normal erections, according to researchers from Taiwan.
Sickle cell disease (SCD) is one of the strongest risk factors for priapism, accounting to 11% to 42% of events. Other common risk factors include drug and alcohol abuse, trauma, spinal cord injury, and medication use.
Phosphodiesterase type 5 (PDE5) inhibitors, which are prescribed to treat erectile dysfunction (ED), do not appear to reduce the risk of developing prostate cancer, according to new research published in the Journal of Urology.
The current study aimed to determine the efficacy of GnRHa treatment in this population in relation to Tanner stage, gonadotropins, and sex steroids. It also investigated the treatment’s effects on liver enzymes, renal function, and changes in body composition.